Ido Agmon

Aviv Bio-Invest functions as an investment fund. The private company is based in Tel Aviv, Israel.

Meytav Technological Enterprises Innovation Center Ltd is an Independent Venture Capital firm founded in 1991. The firm is headquartered in Kiryat Shmona.

ATI Ashkelon Technological Industries Ltd (ATI) is a venture capital subsidiary of Gefen Biomed Investments Ltd founded in 1991. The firm is headquartered in Ashkelon, Israel.

Pep2Life Ltd. develops proprietary novel pro-angiogenic drugs to treat peripheral ischemic disorders. The company started in-vivo experiments to evaluate the pro-angiogenic potential of its lead compound in clinical-relevant models. It presents a novel strategy for therapeutic angiogenesis, which differs from current intervention and from stem cell-based programs in clinical development. Its lead product is a short synthetic peptide, ADoPep1 which targets a cell surface receptor, GRP78 which is only expressed under stress by endothelial cells. Pep2Life was founded in December 2010 and is headquartered in Hertzelia, Israel.

SphinxTech Ltd. develops and manufactures medical devices. It focuses on the research and development of minimally invasive medical devices for the treatment of fecal incontinence. The company was founded in 2005 by Yehiel Ziv and Avinoam Nevler and is headquartered in Kiryat Shmona, Israel.

EZ Orthopedics Ltd. develops medical orthopedics devices. It offers invasive orthopedic fasteners for soft tissue repair, bone fracture fixation, spinal stabilization and prosthetic support. The company was founded by Yosef Freedland in 2004 and is headquartered in Kiryat Shmona, Israel.

CyToD develops therapeutic approach to treat such chronic asthma and rheumatoid arthritis. It focuses on the pathways that restrict homing of specific subsets of immune cells to their activation sites in the lymph nodes and sites of inflammation and thereby fine tune the immune response. The company was founded by Idit Shachar and Liat Flaishon in 2008 and is headquartered in Tel Hai, Israel.